Clinical Trial Update: Safety and Efficacy Study on Cenegermin (Oxervate®) vs Vehicle in Severe Sjogren's Dry Eye Disease (PROTEGO-1 Study) [Phase 3]

View source ↗

Summary

Phase 3 PROTEGO-1 trial comparing cenegermin (Oxervate) to vehicle in severe Sjögren's Dry Eye Disease has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Sjögren Syndrome

Drugs mentioned

• Oxervate (cenegermin)

Snippet

Sponsor: Dompé Farmaceutici S.p.A | Conditions: Dry Eye | Phase 3 | Status: COMPLETED | Results posted: 2024-06-07